Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector
Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation and foster culture of intellectual property. She highlighted how the country, already the world's largest exporter of generics and a major player in vaccine production, can achieve greater value by nurturing innovation.
Mazumdar-Shaw called for a shift in focus toward value creation through innovation. «India ranks 14th in terms of value in the global pharma landscape. We need to invest in R&D and foster a culture of intellectual property to capture greater value,» she said.
Addressing a session during the Global Bio-India 2024 event, she positioned the country as a future global leader in biosciences and innovation.
Mazumdar-Shaw emphasized India's unique advantages in becoming a global bio-innovation hub, citing the nation's rich scientific talent, robust technological capabilities, and entrepreneurial drive.
«Biology is not only the most exciting and transformative field of our time, but it has also become the new frontier where we are pushing the boundaries of human knowledge and capability,» Mazumdar-Shaw said.
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrow's Innovations
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
By — Metla
